Le Lézard
Classified in: Health
Subject: FVT

Diplomat to Release Fourth Quarter and 2017 Year End Financial Results, Provide 2018 Guidance and Host Conference Call On Monday, February 26, 2018


FLINT, Mich., Feb. 20, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that it will release its fourth quarter and 2017 year end financial results and provide 2018 guidance on Monday, February 26, 2018 after market close, with a conference call to follow at 5:00 p.m. ET.

Shareholders and interested participants may listen to a live broadcast of the conference call by dialing 833-640-6814 and referencing conference call ID 5992797 approximately 15 minutes prior to the call. A live webcast of the conference call will be available on the investor relations section of the Company's website and an audio file of the call, as well as supplemental investor information, will be available for 90 days at ir.diplomat.is.

About Diplomat
Diplomat (NYSE: DPLO) is the nation's largest independent provider of specialty pharmacy services?helping patients and providers in all 50 states. The company offers medication management programs for people with complex chronic diseases and delivers unique solutions for manufacturers, hospitals, payors, providers, and more. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients and the rest falls into place." Today, that tradition continues?always focused on improving patient care and clinical adherence. For more information, visit diplomat.is.

Contact
Atul Kavthekar, CFO
810-768-9380 | [email protected]

 

SOURCE Diplomat Pharmacy, Inc.


These press releases may also interest you

at 11:04
MelliCell Inc. has been awarded a U.S. National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $275,000 to conduct research and development (R&D) work on "Industrial Scale Technology for Drug Development in Mature Human...

at 11:00
Eagle Hill Consulting has earned another top workplace award, this time selected by The Washington Business Journal as a 2024 Best Places to Work in the extra-large sized company category. Eagle Hill also has earned multiple best workplace awards...

at 11:00
Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura,...

at 10:53
A one-of-a-kind healthcare collaborative, the Center for Better Aging (CBA) located at St. Bernard Hospital, opens in July with a health equity mandate to serve the growing 50+ population on Chicago's Greater South Side. ...

at 10:46
FullCare Medical has launched a new medical garment production facility in Tatu City, the 5,000-acre mixed-use Special Economic Zone (SEZ) in Kenya....

at 10:45
Moleculin Biotech, Inc., (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced Walter Klemp, President and Chief Executive Officer of...



News published on and distributed by: